Albert Hoffmann's accidental discovery of LSD in 1938 at Sandoz Pharmaceuticals led to significant insights into brain chemistry and mental illness. His work suggested a connection between LSD's effects and serotonin receptors, laying a foundation for understanding conditions like schizophrenia. However, LSD’s severe side effects prevented its therapeutic use. Recently, a team led by David Olson at UC Davis modified LSD's molecular structure to detach its psychedelic properties while retaining therapeutic benefits, aiming for safer treatments for mental health disorders.
Hoffmann's discovery of LSD opened doors to understanding brain function and mental disorders, paving the way for future treatments of conditions like schizophrenia.
Olson's team modified LSD by altering its molecular structure, aiming to retain therapeutic benefits while eliminating psychedelic side effects, representing a significant advance.
The journey from Hoffmann's accidental discovery in 1938 to modern advancements illustrates the evolution of scientific understanding surrounding serotonin receptors and mental health.
By severing key molecular components of LSD, researchers hope to harness its potential for treating mental illnesses without inducing psychosis.
Collection
[
|
...
]